Booming Omics in Schistosoma - Archive ouverte HAL Access content directly
Journal Articles Trends in Parasitology Year : 2020

Booming Omics in Schistosoma


Efforts to eliminate schistosomiasis are hindered by incomplete efficacy of the only FDA-approved antischistosomal drug, praziquantel. By using postgenomic technologies, Wendt et al. and Wang et al. deciphered the function of several genes required for worm survival and pathogenesis, which opens the way for the development of innovative parasite-targeted therapies
Fichier principal
Vignette du fichier
LeGovic-2020-TrendsPara-Booming-MANUSCRIT.pdf (545.06 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-03001273 , version 1 (15-01-2021)



Yohann Le Govic, Benjamin Gourbal, Jérôme Boissier. Booming Omics in Schistosoma. Trends in Parasitology, 2020, 37 (1), pp.6-8. ⟨10.1016/⟩. ⟨hal-03001273⟩
97 View
135 Download



Gmail Mastodon Facebook X LinkedIn More